Evaluation of the combination in PCa PDEs showed a significant reduction in epithelial cell proliferation from 29.42% Ki67 positively stained cells in control-treated PDE tissues to 11.01% upon co-treatment with 4-MU and enzalutamide (Fig. 5h). Here, MKI67 is linked to posterior cortical atrophy.